FAD La comprensione dei bisogni attraverso la condivisione delle differenze
Leggi
Meta-analysis assessing the cardiovascular efficacy of sodium-glucose co-transporter-2 inhibitors according to baseline treatment of interest
Patoulias D, Papadopoulos C, Katsimardou A, Doumas M
Am J Cardiol. Pb. online 15 October 2020
Leggi
Association of maternal prepregnancy diabetes and gestational diabetes mellitus with congenital anomalies of the newborn
Wu Y, Liu B, Sun Y, et al.
Diabetes Care. Pub. online 21 October 2020
Leggi
Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
Packer M, Anker SD, Butler J, et al.
Circulation. Pub. online 21 October 2020
Leggi
Depression and diabetes mellitus multimorbidity is associated with loss of independence and dementia poststroke
Ouk M, Wu CY, Colby-Milley J, et al.
Stroke. Pub. online 14 October 2020
Leggi
NUOVI ANNALI AMD 2020
Carissimi Soci, il virtual meeting Gli Annali AMD 2020 - Presente e Futuro è stato interamente incentrato sulla presentazione dell’ultima pubblicazione degli Annali AMD in uscita in data odierna. Ricordiamo, con orgoglio, che gli Annali fotografano dal 2006 lo scenario del diabete in Italia e rappresentano uno strumento sempre più raffinato…
Leggi
The impact of empagliflozin on obstructive sleep apnea, cardiovascular, and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial
Neeland IJ, Eliasson B, Kasai T et al.
Diabetes Care. 2020 Oct; dc201096.
Leggi
Antidiabetes agents and incident depression: a nationwide population-based study
Kessing LV, Rytgaard HC, Ekstrøm CT et al.
Diabetes Care. 2020 Sep; dc201561
Leggi
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Oshima M, Neuen BL, Jardine MJ, et al.
The Lancet Diabetes & Endocrinology. 2020, Nov; 8 (11):903-914
Leggi